PIM-COVID: Psychological Impact of COVID-19 on Intensive Care Survivors

Sponsor
Royal Liverpool University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05092529
Collaborator
(none)
1,500
45
23.5
33.3
1.4

Study Details

Study Description

Brief Summary

Psychological distress is commonly experienced by survivors of an intensive care admission, including patients treated during previous pandemics. Whilst data emerges about the short-term impact of COVID-19 on patients and healthcare systems, the long term impact remains unclear.

The purpose of this trainee-led, multi-centre longitudinal study is to assess the short- and long-term psychological impact on patients who have survived an admission to intensive care due to COVID-19, and identify possible predictors of anxiety, depression and trauma symptoms in this patient group.

Detailed Description

The primary objective is to identify the proportion of patients surviving an admission to intensive care due to COVID-19 who experience anxiety, depression and/or trauma symptoms in the 6 months post discharge.

Whilst the secondary objectives are to identify demographic, clinical, physical and/or psychosocial predictors of depression, anxiety and/or trauma symptoms at 3-, 6- and 12-months post discharge from ICU. And to assess the feasibility of using a self-reported online questionnaire to assess anxiety, depression and/or trauma symptoms in patients following ICU admission.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Psychological Impact of Surviving an Intensive Care Admission Due to Coronavirus Disease 2019 (COVID-19) on Patients in the United Kingdom
Actual Study Start Date :
Nov 17, 2020
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Anxiety [6 months post intensive care unit (ICU) discharge]

    Hospital Anxiety and Depression Scale (HADS) where a score of 0-7= normal, 8-10= borderline abnormal (borderline case), 11-21= abnormal (case).

  2. Depression [6 months post ICU discharge]

    Hospital Anxiety and Depression Scale (HADS) where a score of 0-7= normal, 8-10= borderline abnormal (borderline case), 11-21= abnormal (case).

  3. Symptoms of trauma [6 months post ICU discharge]

    Impact of Event Scale-6 (IES-6) where the mean score ranges between 0 and 4 and the cut off score is 1.75.

Secondary Outcome Measures

  1. Anxiety [3 and/or 12 months post ICU discharge]

    Hospital Anxiety and Depression Scale (HADS) where a score of 0-7= normal, 8-10= borderline abnormal (borderline case), 11-21= abnormal (case).

  2. Depression [3 and/or 12 months post ICU discharge]

    Hospital Anxiety and Depression Scale (HADS) where a score of 0-7= normal, 8-10= borderline abnormal (borderline case), 11-21= abnormal (case).

  3. Symptoms of trauma [3 and/or 12 months post ICU discharge]

    Impact of Event Scale-6 (IES-6) where the mean score ranges between 0 and 4 and the cut off score is 1.75.

  4. Metacognitive beliefs and processes [3, 6 and/or 12 months post ICU discharge]

    Cognitive Attentional Syndrome Scale-1 (Revised; CAS-1R), which is a 10-item measure with responses scaled from 0%-100%, which are summed to produce a total score. Higher scores indicate greater conviction in metacognitive beliefs and greater use of maladaptive coping strategies to manage distress.

  5. Health-related quality of life [3, 6 and/or 12 months post ICU discharge]

    EuroQol 5-dimension, 5-level questionnaire (EQ-5D-5L) comprises health status measures (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) divided into five levels of perceived problems and a visual analogue scale of health status ranging from 0-100.

  6. Feasibility of using self-reported questionnaire to assess psychological outcomes in ICU survivors with COVID-19 [Study duration, up to 1 year]

    Response rate to invitations to participate/questionnaires.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients ≥18 years

  • Survival to intensive care / high dependency unit discharge following an admission of ≥24 hours

  • Treated for COVID-19

Exclusion Criteria:
  • Unable to complete questionnaires

  • Unable or unwilling to consent

  • Unable to speak, understand or communicate in English

  • Patients with diagnosed, pre-existing cognitive impairment (at the time of ICU admission)

  • Patients without a fixed abode, at which postal questionnaires might be received, and who have no access to a personal email address.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Royal Cornwall Hospital Truro Cornwall United Kingdom TR1 3LJ
2 Barnsley Hospital Barnsley England United Kingdom S75 2EP
3 Basildon Hospital Basildon England United Kingdom SS16 5NL
4 Bedford Hospital Bedford England United Kingdom MK42 9DJ
5 Royal Blackburn Hospital Blackburn England United Kingdom BB2 3HH
6 Pilgrim Hospital Boston England United Kingdom PE21 9QS
7 Royal Papworth Hospital Cambridge England United Kingdom CB2 0AY
8 Cumberland Infirmary Carlisle England United Kingdom CA2 7HY
9 Chesterfield Royal Hospital Chesterfield England United Kingdom S44 5BL
10 Countess of Chester Hospital Chester England United Kingdom CH2 1UL
11 Colchester Hospital Colchester England United Kingdom CO4 5JL
12 Leighton Hospital Crewe England United Kingdom CW1 4QJ
13 Wonford Hospital Exeter England United Kingdom EX2 5DW
14 Queen Elizabeth Hospital Gateshead England United Kingdom NE9 6SX
15 Ipswich Hospital Ipswich England United Kingdom IP4 5PD
16 Kingston Hospital Kingston Upon Thames England United Kingdom KT2 7QB
17 Lincoln County Hospital Lincoln England United Kingdom LN2 5QY
18 Royal Liverpool University Hospital Liverpool England United Kingdom L7 8XP
19 Aintree University Hospital Liverpool England United Kingdom WD18 0HB
20 Lewisham and Greenwich Hospitals London England United Kingdom SE13 6LH
21 King's College Hospital NHS Foundation Trust London England United Kingdom SE5 9RS
22 Macclesfield District General Hospital Macclesfield England United Kingdom SK10 3BL
23 Maidstone Hospital Maidstone England United Kingdom ME16 9QQ
24 James Cook University Hospital Middlesbrough England United Kingdom TS4 3BW
25 Northumbria Healthcare NHS Foundation Trust Newcastle Upon Tyne England United Kingdom NE27 0QJ
26 Newcastle upon Tyne Hospitals Foundation Trust Newcastle Upon Tyne England United Kingdom NE7 7DN
27 Northampton General Hospital Northampton England United Kingdom NN1 5BD
28 Nottingham University Hospitals Nottingham England United Kingdom NG5 1PB
29 Royal Oldham Hospital Oldham England United Kingdom OL1 2JH
30 Derriford Hospital Plymouth England United Kingdom PL6 8DH
31 Whiston Hospital Prescot England United Kingdom L35 5DR
32 Rotherham General Hospital Rotherham England United Kingdom S60 2UD
33 Sheffield Teaching Hospitals NHS Foundation Trust Sheffield England United Kingdom S10 2JF
34 Lister Hospital Stevenage England United Kingdom SG1 4AB
35 King's Mill Hospital Sutton In Ashfield England United Kingdom NG17 4JL
36 Musgrove Park Hospital Taunton England United Kingdom TA1 5DA
37 Tunbridge Wells Hospital Tunbridge Wells England United Kingdom TN2 4QJ
38 Pinderfields General Hospital Wakefield England United Kingdom WF1 4DG
39 Watford General Hospital Watford England United Kingdom WD18 0HB
40 Royal Albert Edward Infirmary Wigan England United Kingdom WN1 2NN
41 Ulster Hospital Belfast Northern Ireland United Kingdom BT16 1RH
42 Forth Valley Royal Hospital Larbert Scotland United Kingdom FK5 4WR
43 University Hospital of Wales Cardiff Wales United Kingdom CF14 4XW
44 Royal Glamorgan Hospital Pontyclun Wales United Kingdom CF72 8XR
45 Morriston Hospital Swansea Wales United Kingdom SA6 6NL

Sponsors and Collaborators

  • Royal Liverpool University Hospital

Investigators

  • Principal Investigator: Alicia AC Waite, Royal Liverpool University Hospital
  • Principal Investigator: Ingeborg D Welters, University of Liverpool

Study Documents (Full-Text)

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Alicia Waite, Postdoctoral Clinical Research Fellow, Royal Liverpool University Hospital
ClinicalTrials.gov Identifier:
NCT05092529
Other Study ID Numbers:
  • SP0316
  • IRAS 282400
  • NIHR CPMS 47545
First Posted:
Oct 25, 2021
Last Update Posted:
Nov 3, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 3, 2021